Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways

H. Shelton Earp, Thomas L. Dawson, Xiong Li, Hong Yu, Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research Breast Cancer Research and Treatment. ,vol. 35, pp. 115- 132 ,(1995) , 10.1007/BF00694752

Masahiro Fukuoka, Seiji Yano, Giuseppe Giaccone, Tomohide Tamura, Kazuhiko Nakagawa, Jean-Yves Douillard, Yutaka Nishiwaki, Johan Vansteenkiste, Shinzoh Kudoh, Danny Rischin, Richard Eek, Takeshi Horai, Kazumasa Noda, Ichiro Takata, Egbert Smit, Steven Averbuch, Angela Macleod, Andrea Feyereislova, Rui-Ping Dong, José Baselga, None, Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 21, pp. 2237- 2246 ,(2003) , 10.1200/JCO.2003.10.038

J Guillermo Paez, Pasi A Janne, Jeffrey C Lee, Sean Tracy, Heidi Greulich, Stacey Gabriel, Paula Herman, Frederic J Kaye, Neal Lindeman, Titus J Boggon, Katsuhiko Naoki, Hidefumi Sasaki, Yoshitaka Fujii, Michael J Eck, William R Sellers, Bruce E Johnson, Matthew Meyerson, EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. ,vol. 304, pp. 1497- 1500 ,(2004) , 10.1126/SCIENCE.1099314

F Chang, J T Lee, P M Navolanic, L S Steelman, J G Shelton, W L Blalock, R A Franklin, J A McCubrey, Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy Leukemia. ,vol. 17, pp. 590- 603 ,(2003) , 10.1038/SJ.LEU.2402824

Gerard V Aranha, Gladell P Paner, Serhan Alkan, Grace Hartman, Kenneth C Micetich, Simone Silberman, Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors. Anticancer Research. ,vol. 23, pp. 2253- 2260 ,(2003)

Jim R Woodburn, Susan E Ashton, Simon P Guy, Keith H Gibson, Brenda J Curry, Andrew J Barker, Alan E Wakeling, ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Research. ,vol. 62, pp. 5749- 5754 ,(2002)

James A. McCubrey, William L. Blalock, John G. Shelton, Linda S. Steelman, Richard Franklin, Patrick M. Navolanic, John T. Lee, Fumin Chang, Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review) International Journal of Oncology. ,vol. 22, pp. 469- 480 ,(2003) , 10.3892/IJO.22.3.469

Valentina Calò, Manuela Migliavacca, Viviana Bazan, Marcella Macaluso, Maria Buscemi, Nicola Gebbia, Antonio Russo, STAT proteins: from normal control of cellular events to tumorigenesis. Journal of Cellular Physiology. ,vol. 197, pp. 157- 168 ,(2003) , 10.1002/JCP.10364

T Kindler, F Breitenbuecher, S Kasper, T Stevens, B Carius, H Gschaidmeier, C Huber, T Fischer, In BCR-ABL-positive cells, STAT-5 tyrosine-phosphorylation integrates signals induced by imatinib mesylate and Ara-C. Leukemia. ,vol. 17, pp. 999- 1009 ,(2003) , 10.1038/SJ.LEU.2402940

Marja T. Nevalainen, Tommi J. Ahonen, Jianwu Xie, Matthew J. LeBaron, Jianqiong Zhu, Martti Nurmi, Kalle Alanen, Hallgeir Rui, Inhibition of Transcription Factor Stat5 Induces Cell Death of Human Prostate Cancer Cells Journal of Biological Chemistry. ,vol. 278, pp. 27287- 27292 ,(2003) , 10.1074/JBC.M304307200